Cartesian Growth Corp II

CM Life Sciences II Inc. currently conducts no substantial business operations. Its primary goal is to complete a strategic business combination, which could involve a merger, stock or asset acquisition, or reorganization, with one or more enterprises within the life sciences field. The company was founded in 2020 and has its headquarters in New York City.

NewHold Investment Corp III currently has no significant ongoing business activities. Its primary objective is to complete a business combination, which could involve a merger, acquisition of assets or shares, or a reorganization with one or more other entities. This company was established in 2024 and operates out of New York, New York.

Cantor Equity Partners II, Inc., does not have significant operations. It intends to focus on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was formerly known as CF International Acquisition Corp. III. The company was incorporated in 2020 and is based in New York, New York.

Texas Ventures Acquisition III Corp currently possesses no significant ongoing business activities. Its explicit objective is to facilitate a strategic business combination, which may take various forms such as a merger, an exchange of equity, an acquisition of assets, a stock purchase, or a corporate reorganization, with one or more existing enterprises. This entity was established in 2024 and is headquartered in Houston, Texas.

Insight Digital Partners II operates as a special purpose acquisition company (SPAC). Its primary objective is to identify and complete a strategic business combination, which could take various forms such as a merger, a capital stock exchange, an asset acquisition, a stock purchase, or a reorganization, with one or more target enterprises. This entity was established on July 11, 2025, and its operations are based in New York, NY.

Currently, Perceptive Capital Solutions Corp possesses no significant active operations. Its principal objective is to execute a strategic business combination—such as a merger, share swap, asset procurement, equity acquisition, or corporate restructuring—with one or more enterprises or entities engaged in the life sciences and medical technology sectors. These prospective partners are sought exclusively within North America or Europe. The company was established in 2024, with its corporate base located in New York, New York.